Toxic epidermal necrolysis and Stevens
Johnson syndrome are potentially life-threatening drug reactions,
which have been effectively treated with intravenous immunoglobulin.
Jennifer Trent, MD
Dr. Trent completed a six year combined BS-MD at the University of
Miami with an undergraduate degree in biology and a minor in chemistry.
While in medical school, she interrupted her formal course to participate
in a two-year research fellowship under the direction of Robert Kirsner,
MD. The focus of her work was hospital care of dermatology patients,
toxic epidermal necrolysis and wound care. Dr. Trent graduated from
Medical School with research distinction and also received the University
of Miami Department of Dermatology's medical student of the year award.
Dr. Trent has published over 40 articles
in peer-reviewed journals and 6 book chapters in various dermatologic
text books on surgery and wound care. She has been interviewed by
the American Academy of Dermatology's Dialogues in Dermatology and
recently published her first book on dermatologic therapy.